Form 4: Halliburton Executive Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Timothy McKeon, Senior VP and Treasurer of Halliburton, sold 10,497 shares of common stock at $24.6 per share on March 7, 2025, under a pre-arranged trading plan.
Summary
- On March 7, 2025, Timothy McKeon, Senior VP and Treasurer of Halliburton, sold 10,497 shares of Halliburton common stock at a price of $24.6 per share.
- The sale was executed under a Rule 10b5-1 trading plan adopted on November 12, 2024.
- Following the transaction, McKeon directly owns 77,784 shares of Halliburton common stock.
- McKeon also holds options to buy common stock at various prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Executive stock sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information. The market will likely interpret this sale in the context of Halliburton's overall performance and industry trends.
Comparison to Industry Standards
- It's common for executives at large companies like Halliburton to have pre-arranged trading plans to diversify their holdings.
- Comparing McKeon's holdings and trading activity to those of executives at similar companies like Schlumberger or Baker Hughes would provide additional context.
- The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading, aligning with industry best practices.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The sale does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/07/2016 | Date of option grant with exercise price of $53.54 and expiration date of 12/02/2026 |
| 12/06/2017 | Date of option grant with exercise price of $43.38 and expiration date of 12/06/2027 |
| 12/05/2018 | Date of option grant with exercise price of $31.44 and expiration date of 12/05/2028 |
| 12/02/2015 | Date of option grant with exercise price of $38.95 and expiration date of 12/02/2025 |
| 11/12/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 03/07/2025 | Date of the stock sale transaction. |
| 03/10/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.